arBtrage CAPITALIZING MARKETS checking… Sign in

Sagimet Biosciences Inc.

SGMT Health Care Biotechnology: Pharmaceutical Preparations
$6.76
▼ -4.2% Today
as of Jun 7, 07:27 ET
Last 30 days -22.74% Apr 28 → Jun 05
$6.36 $7.00 $7.64 $8.29 $8.93 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$7.03
High
$7.11
Low
$6.73
Volume
$608,159
Avg Vol
$960,790
Mkt Cap
$449M
P/E (TTM)
Beta
52w High
$11.41
52w Low
$4.00
Div Yield
Shares Out

Overview

52-week range
$4.00
$11
37% of range
Avg surprise (last 2)
+22.2%
Avg reaction (last 2)
-2.4%
0% positive
Latest IV / EM
147%
EM ±20.3% · $8 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-35.80$-26.91$-18.01$-9.12$-0.23 Actual $-35.80Actual $-0.35Actual $-0.23Actual $-0.25Actual $-0.45Actual $-0.56Est $-0.79Actual $-0.32Actual $-0.40Actual $-0.33Est $-0.39 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-18M$-16M$-13M$-11M$-9M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 12, 2026Mar/2026 $-0.33 $-0.39 +15.4% +41.1% -0.5% earnings
Tue Sep 30, 2025Sep 2025 $-0.40 financials
Mon Jun 30, 2025Jun 2025 $-0.32 financials
Thu May 8, 2025Mar/2025 $-0.56 $-0.79 +29.1% -4.2% earnings
Mon Sep 30, 2024Sep 2024 $-0.45 financials
Sun Jun 30, 2024Jun 2024 $-0.25 financials
Sun Mar 31, 2024Mar 2024 $-0.23 financials
Sat Sep 30, 2023Sep 2023 $-0.35 financials
Fri Jun 30, 2023Jun 2023 $-35.80 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-12M$-14M$-12M$-20M$-17M$-11M
Net income$-11M$-13M$-10M$-18M$-15M$-8M
EPS (diluted)$-0.33$-0.40$-0.32$-0.56$-0.45$-0.25

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$37M$35M$32M$42M$65M$76M$77M$96M
Inventory
Total current assets$108M$116M$119M$127M$146M$153M$157M$167M
Total assets$108M$116M$128M$137M$146M$160M$175M$189M
Long-term debt
Total liabilities$7M$4M$4M$6M
Total equity$102M$111M$119M$130M$139M$156M$171M$183M

Implied volatility — last 90 days

141%144%146%149%151% Jun 07 — IV 147% · EM ±20.3%

Sector peers